GAG
NVO

GM Advisory Group’s Novo Nordisk NVO Stock Holding History

GM Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,616
Closed -$802K – 312
2025
Q2 		$802K Sell
11,616
-2,090
-15% -$142K 0.04% 162
2025
Q1 		$952K Buy
13,706
+11,184
+443% +$924K 0.05% 134
2024
Q4 		$217K Sell
2,522
-311
-11% -$33.6K 0.01% 241
2024
Q3 		$337K Buy
+2,833
New +$378K 0.02% 192

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GM Advisory Group's NVO Position: Q3 2025 in Review

GM Advisory Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 11,616 shares — an estimated $802K sold.

GM Advisory Group first reported a position in NVO in Q3 2024 and held it in 4 quarters. The position peaked at $952K in Q1 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • GM Advisory Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • GM Advisory Group sold 11,616 Novo Nordisk shares in Q3 2025, an estimated $802K.
  • GM Advisory Group first reported a position in Novo Nordisk in Q3 2024 and held it in 4 quarters.
  • GM Advisory Group's Novo Nordisk position peaked at $952K in Q1 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on GM Advisory Group's 13F filing for Q3 2025, filed 19 Nov 2025.